SCHEMBL14169149

SCHEMBL14169149

CNn1cnn(C)c1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13204442 0.64 — —
SCHEMBL10504467 0.59 — —
SCHEMBL22172053 0.59 AADAT (0.35) —
SCHEMBL14505648 0.58 ADORA2B (0.47) —
SCHEMBL5491196 0.58 — —
SCHEMBL22349810 0.57 MAPT (0.64) —
SCHEMBL7898559 0.57 HTR1A (0.36) —
SCHEMBL5486418 0.57 — —
SCHEMBL14561494 0.56 BRD9 (0.33) —
SCHEMBL5491331 0.55 MAP4K4 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022261204-A1 ANTICANCER COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-12-15 — — WO disclosed
US-20080146593-A1 Substituted 5-Phenyl Pyrimidines I In Therapy BASF AKTIENGESELLSCHAFT (DE) 2008-06-19 — — US disclosed
Send feedback